Oncothyreon Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (1995)	4/20/2005 11:08:14 PM
From: Jibacoa	Read Replies (1) of 2344

Biomira begins new cancer vaccine trial. APR. 20 2:51 P.M. ET Canadian biotech company Biomira Inc. and German drug maker Merck KGaA said Wednesday that they started a mid-stage clinical trial for their lung cancer vaccine to support a marketing approval application in Canada. businessweek.com In the mean time, the stock remains on a near term downtrend (but not as bad as the general market.<g>) The nearest support is at 1.95 and resistance at 2.25 The volume lately has remained low. The last high volume day was on Dec.4 when more than 84.8 M shares were traded, and that was an up-day with the price foing from 1.53 to 3.28 (the intra-day H was 3.77) bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next